Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minhee Kang

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Journal of Natural Products|February 20, 2026
Stilbenoids from <i>Vitis amurensis</i> Bind to the GATA-3 DNA-Binding Domain and Inhibit the Transcription by GATA-3Habin Yu, Abdul Bari Shah, Hyunjin Moon, et al.
AIDS Research and Human Retroviruses|March 15, 2016
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and RibavirinTess Petersen, Yu-Jin Lee, Anu Osinusi, et al.
The Journal of Infectious Diseases|September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b studyMark S Sulkowski, Minhee Kang, Roy Matining, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing RevaccinationMinhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Plos One|October 31, 2025
Lacrimispora sanguinis sp. nov., isolated from human bloodHui-Jin Yu, Yun Young Cho, Jayoung Paek, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2023
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency VirusKristen M Marks, Minhee Kang, Triin Umbleja, et al.
Applied Microbiology and Biotechnology|September 19, 2023
Loop-mediated isothermal amplification assay for screening congenital cytomegalovirus infection in newbornsHyeonseek Park, Doo Ri Kim, Areum Shin, et al.
HIV Clinical Trials|December 17, 2013
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trialValerianna K Amorosa, Anne Luetkemeyer, Minhee Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Journal of Natural Products|February 20, 2026
Stilbenoids from <i>Vitis amurensis</i> Bind to the GATA-3 DNA-Binding Domain and Inhibit the Transcription by GATA-3Habin Yu, Abdul Bari Shah, Hyunjin Moon, et al.
AIDS Research and Human Retroviruses|March 15, 2016
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and RibavirinTess Petersen, Yu-Jin Lee, Anu Osinusi, et al.
The Journal of Infectious Diseases|September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b studyMark S Sulkowski, Minhee Kang, Roy Matining, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2025
Hepatitis B Vaccination Histories in Persons with HIV Needing RevaccinationMinhee Kang, Triin Umbleja, Anchalee Avihingsanon, et al.
Plos One|October 31, 2025
Lacrimispora sanguinis sp. nov., isolated from human bloodHui-Jin Yu, Yun Young Cho, Jayoung Paek, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2023
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency VirusKristen M Marks, Minhee Kang, Triin Umbleja, et al.
Applied Microbiology and Biotechnology|September 19, 2023
Loop-mediated isothermal amplification assay for screening congenital cytomegalovirus infection in newbornsHyeonseek Park, Doo Ri Kim, Areum Shin, et al.
HIV Clinical Trials|December 17, 2013
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trialValerianna K Amorosa, Anne Luetkemeyer, Minhee Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Pageof 11